Akero Therapeutics Inc buy Citigroup Inc.
Start price
18.11.24
/
50%
€27.54
Target price
18.11.25
€61.49
Performance (%)
69.39%
End price
19.11.25
€46.65
Summary
This prediction ended on 19.11.25 with a price of €46.65. The BUY prediction by Citigroup_Inc_ for Akero Therapeutics Inc saw massive gains of 69.39%. Citigroup_Inc_ has a follow-up prediction for Akero Therapeutics Inc where he still thinks Akero Therapeutics Inc is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | - | - | - |
| iShares Core DAX® | -6.016% | -4.595% | 1.274% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.573% |
| iShares Nikkei 225® | -7.156% | -2.215% | 28.107% |
| iShares S&P 500 | -0.257% | -0.841% | 10.196% |
Comments by Citigroup_Inc_ for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $65.00 price target on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€35.77
13.05.25
13.05.25
€70.22
13.05.26
13.05.26
31.31%
08.12.25
08.12.25
Stopped prediction by Citigroup_Inc_ for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€53.14
28.01.25
28.01.25
€76.71
28.01.26
28.01.26
-11.61%
29.01.26
29.01.26